hVIVO plc (AIM:HVO)
18.30
+1.05 (6.09%)
May 13, 2025, 4:35 PM GMT+1
hVIVO Revenue
In the year 2024, hVIVO had annual revenue of 66.22M GBP with 12.87% growth. hVIVO had revenue of 29.02M in the half year ending December 31, 2024, a decrease of -8.80%.
Revenue
66.22M
Revenue Growth
+12.87%
P/S Ratio
1.77
Revenue / Employee
219.99K
Employees
301
Market Cap
117.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
hVIVO News
- 4 weeks ago - Cathal Friel to step down as HVivo chairman - Independent Ireland
- 8 months ago - Half Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 8 months ago - Earnings rise 68pc at pharmaceutical services firm Hvivo - Independent Ireland